Cambridge Investment Research Advisors, Inc. Repligen Corp Transaction History

Cambridge Investment Research Advisors, Inc.

  • $29.4 Billion
  • Q3 2024

A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Repligen Corp stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 1,971 shares of RGEN stock, worth $287,214. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,971
Previous 2,115 6.81%
Holding current value
$287,214
Previous $267,000 9.74%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024
SELL
$119.79 - $167.35 $17,249 - $24,098
-144 Reduced 6.81%
1,971 $293,000
Q2 2024

Jul 26, 2024
SELL
$120.0 - $182.95 $11,640 - $17,746
-97 Reduced 4.39%
2,115 $267,000
Q1 2024

Apr 24, 2024
BUY
$170.78 - $208.42 $21,689 - $26,469
127 Added 6.09%
2,212 $407,000
Q4 2023

Feb 09, 2024
BUY
$114.17 - $185.35 $8,448 - $13,715
74 Added 3.68%
2,085 $375,000
Q3 2023

Oct 24, 2023
BUY
$138.78 - $176.51 $138 - $176
1 Added 0.05%
2,011 $320,000
Q2 2023

Jul 13, 2023
SELL
$138.42 - $180.31 $3,045 - $3,966
-22 Reduced 1.08%
2,010 $284,000
Q1 2023

May 11, 2023
SELL
$154.26 - $198.1 $5,861 - $7,527
-38 Reduced 1.84%
2,032 $342,000
Q4 2022

Feb 08, 2023
SELL
$162.42 - $220.56 $113,044 - $153,509
-696 Reduced 25.16%
2,070 $350,000
Q3 2022

Oct 17, 2022
SELL
$160.42 - $256.21 $59,676 - $95,310
-372 Reduced 11.85%
2,766 $517,000
Q2 2022

Jul 13, 2022
SELL
$140.68 - $188.02 $20,820 - $27,826
-148 Reduced 4.5%
3,138 $509,000
Q1 2022

May 12, 2022
SELL
$161.19 - $257.96 $353,650 - $565,964
-2,194 Reduced 40.04%
3,286 $618,000
Q4 2021

Feb 03, 2022
BUY
$247.59 - $304.47 $270,863 - $333,090
1,094 Added 24.94%
5,480 $1.45 Million
Q3 2021

Nov 02, 2021
SELL
$194.77 - $324.21 $196,717 - $327,452
-1,010 Reduced 18.72%
4,386 $1.27 Million
Q2 2021

Aug 10, 2021
BUY
$165.87 - $220.95 $8,625 - $11,489
52 Added 0.97%
5,396 $1.08 Million
Q1 2021

May 07, 2021
BUY
$180.37 - $226.26 $291,117 - $365,183
1,614 Added 43.27%
5,344 $1.04 Million
Q4 2020

Feb 04, 2021
SELL
$148.08 - $206.57 $38,796 - $54,121
-262 Reduced 6.56%
3,730 $714,000
Q3 2020

Oct 29, 2020
BUY
$122.51 - $158.27 $129,125 - $166,816
1,054 Added 35.87%
3,992 $588,000
Q2 2020

Jul 27, 2020
BUY
$94.33 - $140.48 $277,141 - $412,730
2,938 New
2,938 $363,000

Others Institutions Holding RGEN

# of Institutions
476
Shares Held
55.6M
Call Options Held
311K
Put Options Held
235K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.09B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email